New MAVENCLAD (R) Data at ACTRIMS-ECTRIMS MSVirtual2020 Meetin...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, September 11, 2020, /PRNewswire-AsiaNet/-- In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of...
Authors: LATEST ASIANET NEWS RELEASES